LFB BIOPHARMACEUTICALS, takes over the promotion of LFB’s biopharmaceutical products for serious and rare diseases to healthcare professionals, in the United Kingdom.
LFB is a pharmaceutical group specialising in plasma derived or recombinant therapeutic proteins for the treatment of serious and often rare diseases
LFB’s 15 biopharmaceuticals are used for treating disorders that are always serious and often rare
